Ma CE, Ghosh S, Leyshon C, Blosser N, et al. Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI. Leuk Res 2021;111:106674.
PMID: 34333277